Quality Stocks Are Still Holding Ground

MarketWatch.com finally got the sell-off it was trying to provoke. The website has had numerous articles over the past few weeks predicting a major correction. Often, there were two or three a day.

Curiously, now that something has happened, the website right now has only one headline proclaiming a correction: “A market correction is ‘definitely coming’: Carl Icahn. The article evens states “Meanwhile, prominent activist investor Carl Icahn might also have fueled the slide in stocks. The billionaire investor told CNBC that a market correction is “definitely coming,” adding that he’s hedging his stock bets by shorting the S&P 500.

I'll remind everyone that Carl Icahn doesn't have a 100% functional crystal ball. In fact, another headline on MarketWatch.com currently states “Icahn wins with Apple, but loses big on Chesapeake 

I would be inclined to believe a major sell-off is in the works if I saw indications this earnings season may disappoint, or major stocks are dropping on heavy selling. There are companies growing strongly. Many are able to deal with the less-than-stellar economy, the regulatory burden, and the skyrocketing healthcare costs.

Take Actavis (ACT), one of my favorite companies right now. Despite its size, this generic drug company has afterburners lit. It's recent revenue and earnings growth track record leaves Apple's (AAPL) track record far behind. What sells better than iPhones? Drugs.

Actavis doesn't stop there. An Investor's Business Daily/MarketSmith Composite Rating of 99, a ROE of 21%, the number of funds holding ACT has increased 14% over the past year, and so on.

The only problem with this stock is Stochastics refuse to drop into oversold territory, which would create a back-up-the-truck buying opportunity, like in early 2012.

In fact, other top stocks suffer from the same problem. Two of my other favorites are good examples. Polaris Industries (PII) and Ecolab (ECL) just refuse to give good weekly Stochastics ‘buy' signals. The best you can do with ECL is add to existing positions every time ECL pulls back to near the 200-day moving average (which it is working on right now).

Perhaps this is a sign that a correction is likely. Institutions may stop buying until many quality stocks offer true value buying opportunities. Or, they may just continue buying good companies like Actavis, accepting the current P/E of 20 as reasonable considering it has a 34% earnings growth rate.

Of course, there's much more you need to know and many more stocks you can capitalize upon each and every day.  To find out more, please click on the following link: www.markettamer.com/seasonal

By Gregg Harris, MarketTamer Chief Technical Strategist

Copyright (C) 2014 Stock & Options Training LLC

Unless indicated otherwise, at the time of this writing, the author has no positions in any of the above-mentioned securities.

Gregg Harris is the Chief Technical Strategist at MarketTamer.com with extensive experience in the financial sector.

Gregg started out as an Engineer and brings a rigorous thinking to his financial research. Gregg's passion for finance resulted in the creation of a real-time quote system and his work has been featured nationally in publications, such as the Investment Guide magazine.

As an avid researcher, Gregg concentrates on leveraging what institutional and big money players are doing to move the market and create seasonal trend patterns. Using custom research tools, Gregg identifies stocks that are optimal for stock and options traders to exploit these trends and find the tailwinds that can propel stocks to levels that are hidden to the average trader.

The content on any of Market Tamer websites, products, or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options, and other securities involve risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities are not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options (http://www.optionsclearing.com/publications/risks/riskstoc.pdf). The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.

Be Sociable, Share!

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.